NYSE: NTRNutrien Ltd Stock
$58.66-0.46 (-0.78%)
Updated Dec 9, 2025
NTR Price
$58.66
Fair Value Price
N/A
Market Cap
$28.35B
52 Week Low
$43.70
52 Week High
$65.05
P/E
15.77x
P/B
1.13x
P/S
1.07x
PEG
2.28x
Dividend Yield
1.85%
Revenue
$26.62B
Earnings
$1.81B
Gross Margin
30.2%
Operating Margin
11.97%
Profit Margin
6.8%
Debt to Equity
1.06
Operating Cash Flow
$4B
Beta
0.7
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NTR Overview
Nutrien Ltd.'s distributes crop nutrients, crop protection products, and seeds to growers in North and South America and Australia through 2,200 Nutrien Ag Solutions and Landmark Retail stores. Its Potash, Nitrogen, and Phosphate segments offer products derived from their namesake mineral. Nutrien was founded in 2017 and is headquartered in Saskatoon, Saskatchewan, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NTR's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Agricultural Input
Industry Rating
B
NTR
Ranked#3 of 12
Ranked#3 of 12
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $93.97 | A | |
| $65.84 | B | |
| $76.70 | C |
Be the first to know about important NTR news, forecast changes, insider trades & much more!
NTR News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NTR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NTR ($58.66) is trading above its intrinsic value of $30.82, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NTR is good value based on its earnings relative to its share price (15.77x), compared to the US market average (45.87x)
P/E vs Market Valuation
NTR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NTR due diligence checks available for Premium users.
Valuation
NTR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.77x
Industry
19.28x
Market
45.87x
NTR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NTR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NTR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.13x
Industry
1.34x
NTR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NTR price to earnings growth (PEG)
For valuing profitable companies with growth potential
NTR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
NTR's financial health
Profit margin
Revenue
$6.0B
Net Income
$464.0M
Profit Margin
7.7%
NTR's Earnings (EBIT) of $3.19B... subscribe to Premium to read more.
Interest Coverage Financials
NTR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$51.8B
Liabilities
$26.7B
Debt to equity
1.06
NTR's short-term assets ($14.47B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NTR's long-term liabilities ($16.40B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NTR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NTR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$426.0M
Investing
-$383.0M
Financing
$51.0M
NTR's operating cash flow ($4.15B)... subscribe to Premium to read more.
Debt Coverage Financials
NTR vs Agricultural Input Stocks
Nutrien Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.